Ahmed A. Noreldin*; MD, Rama A. Ali*; MD, Ahmed M. Kenawy*; MD, LobnaY.Ghanem**; MD, Abeya A. Lotfy** ;MD, Ahmed S. Ismail***; Msc.
Tamer A Wafa, PhD, MRCS, Abdelrahman Elshafey, PhD, Mostafa El-Ayoty, PhD, Mohamed Elzohiri, PhD
Tamer A Wafa, PhD, MRCS, Abdelrahman Elshafey, PhD, Sherif Abdelmaksoud, PhD, Hesham Sheir, PhD, MRCS, Mohamed El-Ghazaly, PhD
Shaban .M. Abdelmageed and Shawki Sharouda
1Adel A. Sied, 2Mohammed A. Rizk, 2Sherif M. Abdel Aziz
Reda Saad Mohamed Ezz, Mohamed Abd El Monem Rizk, Medhat Mohamed Helmy Khalil, Ahmed Heshmat Soliman Ahmed
Tamer M. Nabil1 M.D, Ahmed H. Khalil2 M.D, MRCS, Mohamed M. Elbarbary3 M.D
Mohamed Abd El-Monem Abd El-Salam Rizk, MD, Mohamed Ismail Mohamed Ismail, MD, Ramez Mounir Wahba , MD
Mohamed Abd El-Monem Abd El-Salam Rizk1, MD, Mohamed Ismail mohamed Ismail1, Ramez Mounir Wahba1,Waleed Anwar Abd El-Mohsen2
Ahmed Sobhy Abbass Ahmed Elsobky
1Yasser M. Salama M.Sc. MRCS, 2Mostafa S. Mahmoud MD
Tarek Ahmed Abd El- Azim, Mostafa Soliman Mahmoud, Mohamed Ismail Mohamed,Ahmad Refaat ELGendi*
Ahmed Serag Emara, Gad Mohamed Behairy, Amr H Afifi
Femoro Popliteal Bypass Vs Angioplasty in TASC D Lesion in Endovascular ERA. Is It Time to Change the TASC Recommendations?
Background: The incidence of CLI is estimated at 1% of the population aged 50 years and older and at
approximately double that rate in the over-70 age group. These frequencies are expected to increase
significantly with the aging population and the expected increase in diabetes. Within 1 year of being
diagnosed with CLI, 40% to 50% of diabetics will experience an amputation, and 20% to 25% will
die. Aim of the Work: Is to discuss whether patients with CLI due to TASC D lesion will still best managed
with femoropopliteal bypass or can be managed by balloon angioplasty that much decreases postoperative
morbidities especially with appearance of new advances in endovascular techniques. Patients and
Methods: This was a prospective randomized comparative study, including 30 patients that attended
outpatient clinic in Ain Shams University Hospital and Nasser Institute Hospital. The patients were divided
into two groups: Group "A" include 15 patients (from1 to 15) underwent bypass surgery and Group "B"
include 15 patients (from 16 to 30) underwent balloon angioplasty. Results: The ages of patients ranged
from 60:70 years old with mean age 65+ 5 Years. In group (A) ABI of the 15 patients increased more than
0.3 postoperative while in group (B) ABI of 9 patients increased more than 0.3 while ABI of 3 patients
showed minimal increase less than 0.3 (and they clinically failed) after exclusion of technical failure group.
As regard to poatency in group (A), primary and secondary patency at 3rd and 6th month was 100% while
in group (B), our three and six months primary patency results were 66.6% and 62.6% respectively while
secondary patency was 88.8% and 87.5% at 3rd and 6th month respectively. In group (A), No patients
underwent major amputation until the 3rd month while in group (B), one patient underwent below knee
amputation at the 3rd month. Conclusion: The overall recommendation is that severe limb ischemia
patients with long life expectancy and useable great saphenous vein, should usually have bypass surgery
first. This is because that saphenous vein bypass surgery has long-term patency results and associates with
significant improved amputation free survival. The rate of balloon angioplasty failure is high, and results
of bypass surgery after failed balloon angioplasty are significantly worse than for primary bypass surgery.
However, patients with short life expectancy (as those who are old aged with multiple comorbidities such
as cardiovascular diseases) and those without a useable vein, should usually have balloon angioplasty first
because they will not survive to reap the longer-term benefits of surgery.
Keywords: Femoro Popliteal Bypass – Angioplasty - Trans Atlantic Inter Society Consensus.